Toyota Motor Corp vs Twist Bioscience Corp — how do they compare? Toyota Motor Corp trades at $180.4 (market cap $212.22B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Toyota Motor Corp is far larger — about 38.9× Twist Bioscience Corp's market cap, and Toyota Motor Corp pays a 3.51% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TM | TWST | |
|---|---|---|
Market Cap | $212.22B | $5.45B |
Sector | Consumer Cyclical | Health |
52-Week High | $248.29 | $102.88 |
52-Week Low | $166.50 | $24.16 |
Enterprise Value | $376.42B | $5.37B |
Dividend Yield | 3.51% | — |
Trailing returns across standard periods
Latest headlines on both assets
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →